NIH-funded research NIH-funded research

Using data to understand different symptoms in mood disorders for better treatment options

Official title: Data-Driven Models of Symptom Heterogeneity to Empower Transdiagnostic Multimodal Biomarker Discovery in Mood Disorders

Funded at Massachusetts General Hospital · NIH-10832541 · Data updated 2026-11-12

This study is looking to make mood disorder treatments better by figuring out how different symptoms respond to various therapies, especially for people getting electroconvulsive therapy (ECT), so that doctors can personalize treatments based on what works best for each person.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 6, 2019
Project endJuly 31, 2025
Funding year2024
Award (this year)$220,389
NIH project number5R00MH119314-05
Project IDNIH-10832541 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with mood disorders, particularly those who may be undergoing electroconvulsive therapy.

Less likely to help

Patients with mood disorders who are not candidates for electroconvulsive therapy or those with other unrelated mental health conditions may not benefit from this research.

What this research studies

This research focuses on improving the treatment of mood disorders by analyzing various symptoms and their responses to different therapies. By utilizing advanced neuroimaging techniques and data-driven analysis, the project aims to identify specific biomarkers that can predict how individual patients will respond to antidepressant treatments. The study will involve patients undergoing electroconvulsive therapy (ECT), collecting MRI and clinical data to better understand the relationship between symptoms and treatment outcomes. This approach seeks to enhance precision medicine in mental health by tailoring treatments to individual needs.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with mood disorders.

How similar studies have gone: Other research in computational psychiatry has shown promise in using data-driven approaches to improve treatment outcomes, indicating that this methodology has potential for success.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Wade, Benjamin Seavey Cutler — Massachusetts General Hospital
  • Study coordinator: Wade, Benjamin Seavey Cutler

Related research

Other NIH-funded projects on the same topics.

  • Understanding gene activity in the brains of people with mood disorders who died by suicide

    A study to map which genes are active in brain cells and where they are in the brains of people with mood disorders who attempted or died by suicide, using advanced single-cell and spatial techniques.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-11349216

  • Synaptic changes in mood disorders and suicide risk

    This project studies brain Synapse signals in people with mood disorders, including those with a recent suicide attempt, to understand what changes are linked to suicide risk and how ketamine might work.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-11349215

  • Integrating immune and brain reward biology in veterans with mood problems

    A study in veterans with mood disorders looks at how the immune system and brain reward circuits may work together to drive depression and suicide risk.

    NIH research James J Peters VA Medical Center · Bronx, United States · NIH-11320777

  • Mindfulness to reduce mood swings in teens at risk for mood disorders

    This project teaches mindfulness skills to teens and young adults with family histories of mood disorders to help reduce frequent mood swings and improve sustained attention.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11285153

  • Understanding how calcium channels affect substance use and mood disorders

    This study is looking at how problems with drugs and mood can affect each other, especially when someone is trying to stay off drugs, and it’s testing how certain brain channels might help us find better treatments for people dealing with both issues.

    NIH research Yale University · New Haven, United States · NIH-11144027

  • Exploring the link between immune system issues and mood disorders in veterans

    This study is looking at how problems with the immune system might affect mood and increase the risk of suicide in veterans, using blood tests and brain scans to find clues that could help improve diagnosis and treatment for those dealing with depression.

    NIH research James J Peters VA Medical Center · Bronx, United States · NIH-11052103

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.